Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Dia-Präsentation von SERVIER
EUROPA-Studie (Perindopril) (60 Abbildungen)
Übersicht
Gesamtpräsentation zum Download (rechte Maustaste und "Ziel speichern unter..." klicken)


Zum ersten Bild Abb. 31: EUROPA-Studie - Zentren Abb. 32: EUROPA-Studie - Ausschlußkriterien Abb. 33: EUROPA-Studie - Charakteristika Aktuelles Bild - Abb. 34: EUROPA-Studie - Anamnese Abb. 35: EUROPA-Studie - Risikofaktoren Abb. 36: EUROPA-Studie - Medikation Abb. 37: EUROPA-Studie - Resultate Zum letzten Bild
Abbildung 34: EUROPA-Studie - Anamnese
There were 65 % of patients with previous history of MI, 83 % of those with MI was more than 1 year in the past, 1/3 of them had an MI 5 years before study started. Half of the patients randomised had revascularisation, and small % of patients had peripheral vascular disease, history of stroke or TIA and 1.3 had heart failure as it was the exclusion criteria, all equally balanced between perindopril and placebo group.
 
EUROPA-Studie - Anamnese
Vorheriges Bild Nächstes Bild   


Abbildung 34: EUROPA-Studie - Anamnese
There were 65 % of patients with previous history of MI, 83 % of those with MI was more than 1 year in the past, 1/3 of them had an MI 5 years before study started. Half of the patients randomised had revascularisation, and small % of patients had peripheral vascular disease, history of stroke or TIA and 1.3 had heart failure as it was the exclusion criteria, all equally balanced between perindopril and placebo group.
 
copyright © 2003–2017 Krause & Pachernegg GmbH | Sitemap | Impressum
 
Werbung